Gabriel Gomez, MD

Title(s)Assistant Professor of Clinical Otolaryngology
SchoolKeck School of Medicine of USC
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Molemans M, Vernooij E, Dlamini N, Shabalala FS, Khan S, van Leth F, Gomez GB, Reis R. Changes in disclosure, adherence and healthcare interactions after the introduction of immediate ART initiation: an analysis of patient experiences in Swaziland. Trop Med Int Health. 2019 Feb 10. PMID: 30739385.
      View in: PubMed
    2. Gomez G, Chen PG. Tympanostomy tube placement and ear drops: Evidence-based cost saving models. Int J Pediatr Otorhinolaryngol. 2018 Jul; 110:110-113. PMID: 29859569.
      View in: PubMed
    3. Gomez GB, Rupert S, Houben RMGJ. Economic evaluation of TB screening programmes in migrants: need for a comprehensive framework. Int J Tuberc Lung Dis. 2017 09 01; 21(9):953. PMID: 28826440.
      View in: PubMed
    4. Tracy LF, Gomez G, Overton LJ, McClain WG. Hypovolemic shock after labial and lingual frenulectomy: A report of two cases. Int J Pediatr Otorhinolaryngol. 2017 Sep; 100:223-224. PMID: 28802376.
      View in: PubMed
    5. Menzies NA, Gomez GB, Bozzani F, Chatterjee S, Foster N, Baena IG, Laurence YV, Qiang S, Siroka A, Sweeney S, Verguet S, Arinaminpathy N, Azman AS, Bendavid E, Chang ST, Cohen T, Denholm JT, Dowdy DW, Eckhoff PA, Goldhaber-Fiebert JD, Handel A, Huynh GH, Lalli M, Lin HH, Mandal S, McBryde ES, Pandey S, Salomon JA, Suen SC, Sumner T, Trauer JM, Wagner BG, Whalen CC, Wu CY, Boccia D, Chadha VK, Charalambous S, Chin DP, Churchyard G, Daniels C, Dewan P, Ditiu L, Eaton JW, Grant AD, Hippner P, Hosseini M, Mametja D, Pretorius C, Pillay Y, Rade K, Sahu S, Wang L, Houben RMGJ, Kimerling ME, White RG, Vassall A. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. Lancet Glob Health. 2016 11; 4(11):e816-e826. PMID: 27720689.
      View in: PubMed
    6. Houben RMGJ, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, Lin HH, Wu CY, Mandal S, Pandey S, Suen SC, Bendavid E, Azman AS, Dowdy DW, Bacaër N, Rhines AS, Feldman MW, Handel A, Whalen CC, Chang ST, Wagner BG, Eckhoff PA, Trauer JM, Denholm JT, McBryde ES, Cohen T, Salomon JA, Pretorius C, Lalli M, Eaton JW, Boccia D, Hosseini M, Gomez GB, Sahu S, Daniels C, Ditiu L, Chin DP, Wang L, Chadha VK, Rade K, Dewan P, Hippner P, Charalambous S, Grant AD, Churchyard G, Pillay Y, Mametja LD, Kimerling ME, Vassall A, White RG. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Lancet Glob Health. 2016 11; 4(11):e806-e815. PMID: 27720688.
      View in: PubMed
    7. Knight GM, Gomez GB, Dodd PJ, Dowdy D, Zwerling A, Wells WA, Cobelens F, Vassall A, White RG. The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa. PLoS One. 2015; 10(12):e0145796. PMID: 26717007; PMCID: PMC4696677.
    8. Günther G, Gomez GB, Lange C, Rupert S, van Leth F. Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey. Eur Respir J. 2015 Apr; 45(4):1081-8. PMID: 25395035.
      View in: PubMed